Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

592 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New developments and controversies in the neuropathology of malignant gliomas.
Wiestler OD, Schmidt MC, von Deimling A, Reifenberger G, Deckert-Schlüter M, Radner H, Pietsch T. Wiestler OD, et al. Among authors: pietsch t. Front Radiat Ther Oncol. 1999;33:123-38. doi: 10.1159/000061229. Front Radiat Ther Oncol. 1999. PMID: 10549483 Review. No abstract available.
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91.
Hoff KV, Hinkes B, Gerber NU, Deinlein F, Mittler U, Urban C, Benesch M, Warmuth-Metz M, Soerensen N, Zwiener I, Goette H, Schlegel PG, Pietsch T, Kortmann RD, Kuehl J, Rutkowski S. Hoff KV, et al. Among authors: pietsch t. Eur J Cancer. 2009 May;45(7):1209-1217. doi: 10.1016/j.ejca.2009.01.015. Epub 2009 Feb 26. Eur J Cancer. 2009. PMID: 19250820 Clinical Trial.
Surgery for spinal cord ependymomas: outcome and prognostic factors.
Boström A, von Lehe M, Hartmann W, Pietsch T, Feuss M, Boström JP, Schramm J, Simon M. Boström A, et al. Among authors: pietsch t. Neurosurgery. 2011 Feb;68(2):302-8; discussion 309. doi: 10.1227/NEU.0b013e3182004c1e. Neurosurgery. 2011. PMID: 21135741
Treatment results in patients with intracranial ependymomas.
Boström A, Boström J, Hartmann W, Pietsch T, Feuss M, von Lehe M, Simon M. Boström A, et al. Among authors: pietsch t. Cent Eur Neurosurg. 2011 Aug;72(3):127-32. doi: 10.1055/s-0031-1273745. Epub 2011 May 31. Cent Eur Neurosurg. 2011. PMID: 21630189
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society. Herrlinger U, et al. Among authors: pietsch t. Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30782343 Free article. Clinical Trial.
592 results